High density lipoprotein subfractions and paraoxonase 1 in children

被引:9
|
作者
Muchova, Jana [1 ]
Andrezalova, Lucia [1 ]
Oravec, Stanislav [2 ]
Nagyova, Zuzana [3 ]
Garaiova, Iveta [4 ]
Durackova, Zdenka [1 ]
机构
[1] Comenius Univ, Fac Med, Inst Med Chem Biochem & Clin Biochem, Bratislava, Slovakia
[2] Comenius Univ, Fac Med, Dept Internal Med 2, Bratislava, Slovakia
[3] Juvenalia Paediat Ctr, Dunajska Streda, Slovakia
[4] Cultech Ltd, Res Dept, Unit, Port Talbot SA12 7BZ, Wales
关键词
lipoproteins; LDL-lipoproteins; HDL-lipoproteins; children; paraoxonase; 1; HOMOCYSTEINE-THIOLACTONASE ACTIVITY; SERUM PARAOXONASE; OXIDATIVE STRESS; HEART-DISEASE; HDL SUBCLASSES; PARTICLE-SIZE; PON1; PROTEIN; IN-VITRO; LDL; HYPERCHOLESTEROLEMIA;
D O I
10.18388/abp.2015_1230
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Lipoprint system (Quantimetrix Corp., CA, USA), enables the determination of 10 high density lipoprotein (HDL) subfractions in contrast to the 5 HDL subfractions that can be determined by ultracentrifuge analysis. HDL subfractions, and their relationships to the arylesterase (PON1-A) and lactonase (PON1-L) activities of paraoxonase 1 (PON1), together with total-, very low density lipoprotein- and low density lipoprotein (LDL)-cholesterol and LDL subfractions were investigated in the serum of 27 mildly hypercholesterolemic children and 21 healthy controls. Our results suggest the antiatherogenity of large HDL (L-HDL) subfractions and the atherogenity of small HDL (S-HDL) subfractions in the study groups. However, the relationship between the intermediate HDL (I-HDL) subfractions with the LDL subfractions and other lipoproteins did not suggest that I-HDL subfractions are antiatherogenic. No significant association between PON1-A and the HDL subfractions was found. In contrast, PON1-L activity positively correlated with the antiatherogenic large HDL1 subfraction and negatively with intermediate HDL subfractions 4, 5 and 6. Our results contribute to the knowledge of the roles of total HDL and ten individual HDL subfractions in children and adolescents.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 50 条
  • [1] Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity
    Harangi, Mariann
    Mirdamadi, Hossein Z.
    Seres, Ildiko
    Ferenc Sztanek
    Miklos Molnar
    Kassai, Andrea
    Derdak, Zoltan
    Laszlo Illyes
    Gyorgy Paragh
    TRANSLATIONAL RESEARCH, 2009, 153 (04) : 190 - 198
  • [2] Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection
    Khalil, Abdelouahed
    Fulop, Tamas
    Berrougui, Hicham
    ANTIOXIDANTS & REDOX SIGNALING, 2021, 34 (03) : 191 - 200
  • [3] Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction
    Gu, Xiaodong
    Huang, Ying
    Levison, Bruce S.
    Gerstenecker, Gary
    DiDonato, Anthony J.
    Hazen, Leah B.
    Lee, Joonsue
    Gogonea, Valentin
    DiDonato, Joseph A.
    Hazen, Stanley L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (04) : 1890 - 1904
  • [4] Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy
    Li, Chengjiang
    Gu, Qing
    NEPHROLOGY, 2009, 14 (05) : 514 - 520
  • [5] Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein
    Gugliucci, Alejandro
    Caccavello, Russell
    Kotani, Kazuhiko
    Kimura, Satoshi
    REDOX REPORT, 2014, 19 (04) : 154 - 160
  • [6] Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease
    Kim, Daniel Seung
    Marsillach, Judit
    Furlong, Clement E.
    Jarvik, Gail P.
    PHARMACOGENOMICS, 2013, 14 (12) : 1495 - 1515
  • [7] Low High-Density Lipoprotein Cholesterol Is Not Responsible for Decreased Paraoxonase Activity in Chronic Renal Failure
    Varga, Eva
    Seres, Ildiko
    Harangi, Mariann
    Karpati, Istvan
    Koncsos, Peter
    Sztanek, Ferenc
    Paragh, Gyorgy
    KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 35 (04) : 265 - 272
  • [8] The role of paraoxonase 1 in regulating high-density lipoprotein functionality during aging
    Khalil, Abdelouahed
    Simo, Olivier Kamtchueng
    Ikhlef, Souade
    Berrougui, Hicham
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2017, 95 (10) : 1254 - 1262
  • [9] Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice
    Zhao, Xiao-Jie
    Liu, Liang-Chen
    Guo, Cui
    Shen, Wen-Wen
    Cao, Jia
    Du, Fen
    Wu, Dong-Fang
    Yu, Hong
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (13)
  • [10] Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
    Beekhof, Piet K.
    Gorshunska, Maryana
    Jansen, Eugene H. J. M.
    LIPIDS IN HEALTH AND DISEASE, 2012, 11